account_balance
Investment manager · 13F filer · SEC CIK 1913464
AlphaCentric Advisors LLC
Reported value$113Mas of Sep 30, 2026
Positions245 33 new, 47 sold out
Top 10 weight23.4%SHY alone is 5%
FiledNov 334 days after quarter end
Portfolio · as of Sep 30, 2026
Where the money is
New or addedTrimmedHeld
SHYiShares Tr
4.8%Added +410%
GILDGilead Sciences Inc
2.8%Added +4%
IWDiShares Tr
2.6%Added +108%
RPVInvesco Exchange Traded Fd T
2.6%Added +110%
VRTXVertex Pharmaceuticals Inc
2.4%Added +2%
INVHInvitation Homes Inc
1.7%
AZNAstrazeneca PLC
1.7%Added +4%
ROIVRoivant Sciences Ltd
1.6%Added +5%
INCYIncyte Corp
1.6%Added +5%
ARGXArgenx Se
1.6%
NBIXNeurocrine Biosciences Inc
1.3%Added +5%
INSMInsmed Inc
1.2%Added +4%
SHYiShares Tr
4.8%Added +410%
GILDGilead Sciences Inc
2.8%Added +4%
IWDiShares Tr
2.6%Added +108%
RPVInvesco Exchange Traded Fd T
2.6%Added +110%
VRTXVertex Pharmaceuticals Inc
2.4%Added +2%
INVH1.7%AZN1.7%ROIV1.6%INCY1.6%ARGX1.6%NBIX1.3%INSM1.2%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
SHY iShares Tr 4.8% Added +410%GILD Gilead Sciences Inc 2.8% Added +4%IWD iShares Tr 2.6% Added +108%RPV Invesco Exchange Traded Fd T 2.6% Added +110%VRTX Vertex Pharmaceuticals Inc 2.4% Added +2%INVH Invitation Homes Inc 1.7% HeldAZN Astrazeneca PLC 1.7% Added +4%ROIV Roivant Sciences Ltd 1.6% Added +5%INCY Incyte Corp 1.6% Added +5%ARGX Argenx Se 1.6% HeldNBIX Neurocrine Biosciences Inc 1.3% Added +5%INSM Insmed Inc 1.2% Added +4%
What changed